The hyperglycemic-glycogenolytic factor, Glucagon(1, 5), has been used extensively in our hospital(10) and elsewhere as an additional agent(2, 7, 8, 9) in Insulin Coma Therapy for rousing patients from deep coma so that they can swallow a sugar solution. Glucagon is thought to act by producing a transitory hyperglycemia due to its glycogenolytic action on the liver glycogen. One of us (KTD) assumed that perhaps 2
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.